$3.07 Million is the total value of Camber Capital Management LP's 38 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 17.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UHS | UNIVERSAL HLTH SVCS INCcl b | $303,707 | +24.1% | 1,925,000 | 0.0% | 9.89% | +31.4% | |
| THC | Sell | TENET HEALTHCARE CORP | $260,416 | +13.8% | 3,200,000 | -16.9% | 8.48% | +20.5% |
| VTRS | VIATRIS INC | $224,550 | +3.7% | 22,500,000 | 0.0% | 7.31% | +9.9% | |
| SNY | Sell | SANOFIsponsored adr | $215,600 | -28.0% | 4,000,000 | -27.3% | 7.02% | -23.7% |
| WBA | Buy | WALGREENS BOOTS ALLIANCE INC | $213,675 | -4.9% | 7,500,000 | +15.4% | 6.96% | +0.7% |
| MYGN | Sell | MYRIAD GENETICS INC | $153,799 | -5.4% | 6,635,000 | -5.2% | 5.01% | +0.1% |
| ZBH | Sell | ZIMMER BIOMET HOLDINGS INC | $152,880 | -5.3% | 1,050,000 | -16.0% | 4.98% | +0.2% |
| Sell | GSK PLCsponsored adr | $146,124 | -10.7% | 4,100,000 | -10.9% | 4.76% | -5.5% | |
| BAX | BAXTER INTL INC | $136,680 | +12.3% | 3,000,000 | 0.0% | 4.45% | +18.9% | |
| SEM | Sell | SELECT MED HLDGS CORP | $129,033 | +4.0% | 4,050,000 | -15.6% | 4.20% | +10.1% |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $102,575 | +49.1% | 2,500,000 | +29.9% | 3.34% | +57.8% |
| PTCT | PTC THERAPEUTICS INC | $101,675 | -16.0% | 2,500,000 | 0.0% | 3.31% | -11.1% | |
| PRGO | PERRIGO CO PLC | $84,875 | -5.4% | 2,500,000 | 0.0% | 2.76% | +0.2% | |
| QTRX | QUANTERIX CORP | $77,234 | +100.1% | 3,425,000 | 0.0% | 2.52% | +111.9% | |
| BKD | BROOKDALE SR LIVING INC | $75,960 | +43.1% | 18,000,000 | 0.0% | 2.47% | +51.4% | |
| XRAY | DENTSPLY SIRONA INC | $70,635 | +1.9% | 1,765,000 | 0.0% | 2.30% | +7.9% | |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $65,034 | +24.9% | 1,800,000 | +28.6% | 2.12% | +32.3% |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $64,005 | +141.1% | 8,500,000 | +183.3% | 2.08% | +155.4% |
| GMED | Buy | GLOBUS MED INCcl a | $59,540 | +244.7% | 1,000,000 | +227.9% | 1.94% | +265.2% |
| MDT | New | MEDTRONIC PLC | $52,860 | – | 600,000 | +100.0% | 1.72% | – |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $45,808 | -55.7% | 400,000 | -46.7% | 1.49% | -53.1% |
| ZIMVIE INC | $36,498 | +55.3% | 3,250,000 | 0.0% | 1.19% | +64.3% | ||
| HLF | Buy | HERBALIFE LTD | $36,410 | +174.1% | 2,750,000 | +233.3% | 1.19% | +190.7% |
| REPL | Buy | REPLIMUNE GROUP INC | $35,991 | +63.0% | 1,550,000 | +24.0% | 1.17% | +72.6% |
| EXEL | EXELIXIS INC | $29,621 | -1.5% | 1,550,000 | 0.0% | 0.96% | +4.3% | |
| CNC | CENTENE CORP DEL | $26,980 | +6.7% | 400,000 | 0.0% | 0.88% | +13.0% | |
| PTON | Buy | PELOTON INTERACTIVE INC | $23,070 | +171.3% | 3,000,000 | +300.0% | 0.75% | +186.6% |
| COLL | COLLEGIUM PHARMACEUTICAL INC | $22,565 | -10.4% | 1,050,000 | 0.0% | 0.74% | -5.2% | |
| OSUR | ORASURE TECHNOLOGIES INC | $21,293 | -17.2% | 4,250,000 | 0.0% | 0.69% | -12.4% | |
| BROOKDALE SR LIVING INCunit 11/15/2025 | $15,504 | +33.9% | 250,000 | 0.0% | 0.50% | +41.9% | ||
| CVAC | Buy | CUREVAC N V | $15,239 | +74.9% | 1,462,500 | +17.0% | 0.50% | +85.1% |
| PBYI | PUMA BIOTECHNOLOGY INC | $14,950 | +14.2% | 4,235,000 | 0.0% | 0.49% | +21.1% | |
| SKIN | Buy | THE BEAUTY HEALTH COMPANY | $14,648 | +132.0% | 1,750,000 | +250.0% | 0.48% | +145.9% |
| INGN | Buy | INOGEN INC | $13,283 | +9.2% | 1,150,000 | +17.9% | 0.43% | +15.8% |
| GKOS | Sell | GLAUKOS CORP | $11,394 | -35.0% | 160,000 | -54.3% | 0.37% | -31.2% |
| SOLID BIOSCIENCES INC | $7,433 | +10.6% | 1,418,439 | 0.0% | 0.24% | +16.9% | ||
| CANO | CANO HEALTH INC | $5,560 | +52.7% | 4,000,000 | 0.0% | 0.18% | +61.6% | |
| DVAX | New | DYNAVAX TECHNOLOGIES CORP | $3,876 | – | 300,000 | +100.0% | 0.13% | – |
| NSTG | Exit | NANOSTRING TECHNOLOGIES INC | $0 | – | -1,500,000 | -100.0% | -0.46% | – |
| ALGN | Exit | ALIGN TECHNOLOGY INC | $0 | – | -50,000 | -100.0% | -0.51% | – |
| NUVA | Exit | NUVASIVE INC | $0 | – | -600,000 | -100.0% | -0.76% | – |
| CNMD | Exit | CONMED CORP | $0 | – | -325,000 | -100.0% | -1.04% | – |
| QQQ | Exit | INVESCO QQQ TRput | $0 | – | -1,000,000 | -100.0% | -9.87% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEVA PHARMACEUTICALS INDS LTD | 34 | Q3 2023 | 9.7% |
| BROOKDALE SR LIVING INC | 32 | Q3 2023 | 5.0% |
| PERRIGO CO PLC | 29 | Q3 2023 | 7.1% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 8.5% |
| NEKTAR THERAPEUTICS | 28 | Q1 2022 | 9.8% |
| UNIVERSAL HLTH SVCS INC | 25 | Q3 2023 | 9.9% |
| MYRIAD GENETICS INC | 24 | Q3 2023 | 5.0% |
| SAREPTA THERAPEUTICS INC | 23 | Q3 2023 | 6.0% |
| MYLAN NV | 21 | Q3 2020 | 10.1% |
| AMAG PHARMACEUTICALS INC | 21 | Q3 2020 | 4.0% |
View Camber Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC | February 02, 2023 | ? | ? |
| Solid Biosciences Inc. | December 12, 2022 | ? | ? |
| AVROBIO, Inc. | February 14, 2022 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 14, 2022 | ? | ? |
| AMAG PHARMACEUTICALS, INC. | February 16, 2021 | ? | ? |
| Atara Biotherapeutics, Inc. | February 16, 2021 | ? | ? |
| Change Healthcare Inc. | February 16, 2021 | ? | ? |
| GLYCOMIMETICS INC | February 16, 2021 | ? | ? |
| Clovis Oncology, Inc. | February 14, 2020 | ? | ? |
| Cyclerion Therapeutics, Inc. | February 14, 2020 | ? | ? |
View Camber Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-30 |
| 13F-HR | 2023-08-14 |
View Camber Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.